The Norwegian Radium Hospital, The Research Building
In November six research prizes were awarded to scientists from Oslo University Hospital. CCB postdoc Sigrid Thoresen was among the prize winners with her Nature Cell Biology article.
PhD students Nadja Katheder and Tor Espen Torvaldsen from Harald Stenmark's group, were honored with prizes for best short talk and best poster presentation, respectively, at international conferences this autumn. Congratulations!
Edward Leithe receives the 2014 Early Career Award from Oslo University Hospital. The award is presented to Leithe for his contributions to the field of connexins and intercellular communication in cancer pathogenesis. The prize is given annually to two researchers at Oslo University Hospital and carries an award of 150.000 NOK to support the recipients’ research projects.
CCB director Harald Stenmark received King Olav V’s Cancer Research Award 2014 for his ground-breaking discoveries within cell biology in a ceremony on the 2nd of June in the old ceremonial hall at the University of Oslo.
Jarle Bruun defended his thesis "Biomarkers with functional and clinical impact on colorectal cancer" the 24th of April, with professor David Kerr, University of Oxford, and professor Leonor David, University of Porto, as opponents.
Bruun’s work was presented in Dagens Medisin the 24th of April and on forskning.no the 17th of May.
In a recent Article in Nature Cell Biology, PhD student Sigrid B. Thoresen and her co-workers in Harald Stenmark’s group at Institute for Cancer Research and Centre for Cancer Biomedicine have uncovered a cellular mechanism that prevents completion of cell division if “lagging” chromosomes are detected in the bridge between the two forming daughter cells. This prevents occurrence of cells with abnormal numbers of chromosomes, aneuploidy. Since aneuploidy is strongly associated with cancer progression, these results open new possibilities for future cancer diagnosis and therapy.
The Fridtjof Nansen prize for excellent research in science and medicine 2014 is awarded to CCB's Kirsten Sandvig for her groundbreaking work within biochemistry and cell biology.
In April six research prizes were awarded to scientists from Oslo University Hospital. CCB researcher Marianne B. Eide was among the prize winners.
Wednesday the 30th of April, Group leader Guro E. Lind participated in the radio program Ekko to talk about epigenetics and colorectal cancer.
Lind was invited speaker at the Oslo Epigenetics Symposium that took place from the 9th-11th of April. The Ekko program based its news story on this important international conference.
CCB's PhD student Åsmund Husabø Eikenes has contributed with two new articles disseminating his own research field, as well as inspirational thoughts about PhD student life: One in the Norwegian newspaper Aftenposten about a revolutionizing technique for gene modification. The other one on forskning.no about his 8 months' stay at the University of California.
The Norwegian Cancer Society hosted on the 31st of January a press conference about the use of nanoparticles in cancer diagnosis and therapy. This event was the Norwegian contribution to the European initiative Nano World Cancer Day 2014 with similar press conferences arranged at the same time in 13 European countries.
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the month". For the month of January 2014, this honor goes to CCB's group leader Guro Elisabeth Lind from the Department of Cancer Prevention at the Institute for Cancer Research, the Norwegian Radium Hospital.
We congratulate CCB's PhD student Åsmund Husabø Eikenes with "Hjernekraftprisen 2013". The prize supports and promotes science dissemination, and is part of the campaign Hjernekraftverk highlighting the societal importance of investing in research and development.